Free Trial

Avadel Pharmaceuticals (AVDL) SEC Filings & 10K Form

Avadel Pharmaceuticals logo
$12.22 +1.12 (+10.10%)
As of 10:04 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Recent Avadel Pharmaceuticals SEC Filings

DateFilerForm TypeView
07/16/2025
6:02 PM
Avadel Pharmaceuticals (Subject)
BlackRock, Inc. (Filed by)
Form SCHEDULE 13G/A
07/14/2025
11:31 AM
ASL Strategic Value Fund, LP (Filed by)
Avadel Pharmaceuticals (Subject)
Form PX14A6G
06/30/2025
9:56 AM
ASL Strategic Value Fund, LP (Filed by)
Avadel Pharmaceuticals (Subject)
Form PX14A6G
06/18/2025
6:01 AM
Avadel Pharmaceuticals (Filer)
Form DEF 14A
06/18/2025
6:03 AM
Avadel Pharmaceuticals (Filer)
Form DEFA14A
06/18/2025
6:05 AM
Avadel Pharmaceuticals (Filer)
Form ARS
06/05/2025
6:34 AM
Avadel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/14/2025
11:00 AM
Avadel Pharmaceuticals (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
Form SCHEDULE 13G/A
05/13/2025
5:00 PM
Avadel Pharmaceuticals (Issuer)
Rodriguez Susan (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
05/13/2025
5:01 PM
Avadel Pharmaceuticals (Issuer)
Rodriguez Susan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/13/2025
3:22 PM
Avadel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/07/2025
8:20 AM
Avadel Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/07/2025
6:07 AM
Avadel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/06/2025
1:59 PM
Avadel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/08/2025
2:01 PM
Avadel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/07/2025
3:45 PM
Avadel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/03/2025
8:16 AM
Avadel Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/03/2025
6:09 AM
Avadel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2025
10:55 AM
Avadel Pharmaceuticals (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
Form SCHEDULE 13G/A
01/28/2025
3:22 PM
Avadel Pharmaceuticals (Issuer)
Palczuk Linda (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/14/2025
3:22 PM
Avadel Pharmaceuticals (Issuer)
Ende Eric J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/14/2025
3:24 PM
Avadel Pharmaceuticals (Issuer)
Thornton Peter J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2025
3:18 PM
Avadel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/27/2024
3:15 PM
Avadel Pharmaceuticals (Issuer)
Palczuk Linda (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/19/2024
3:20 PM
Avadel Pharmaceuticals (Issuer)
Palczuk Linda (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2024
6:00 AM
Avadel Pharmaceuticals (Issuer)
MCHUGH THOMAS S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/12/2024
6:00 AM
Avadel Pharmaceuticals (Issuer)
MCHUGH THOMAS S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2024
5:13 PM
Avadel Pharmaceuticals (Issuer)
Glass Geoffrey Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2024
5:14 PM
Avadel Pharmaceuticals (Issuer)
Divis Gregory J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2024
6:00 AM
Avadel Pharmaceuticals (Issuer)
Palczuk Linda (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/03/2024
5:02 AM
Avadel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
10:50 AM
Avadel Pharmaceuticals (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
Form SC 13G/A
11/14/2024
5:10 AM
Avadel Pharmaceuticals (Subject)
RTW INVESTMENTS, LP (Filed by)
Form SC 13G/A
11/13/2024
4:58 PM
Avadel Pharmaceuticals (Subject)
Polar Capital Holdings Plc (Filed by)
Form SC 13G/A
11/12/2024
6:06 AM
Avadel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/31/2024
6:07 AM
Avadel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/17/2024
9:34 AM
Avadel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/16/2024
4:18 PM
Avadel Pharmaceuticals (Issuer)
Palczuk Linda (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/13/2024
5:01 PM
Avadel Pharmaceuticals (Issuer)
Glass Geoffrey Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/12/2024
6:00 AM
Avadel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/28/2024
6:00 AM
Avadel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
My #1 Pre IPO Trade for 2025 (Ad)

SpaceX value has surged to $350 billion... Delivering windfall profits to early investors including Elon Musk and Peter Theil. Right now, you can invest in "the next SpaceX" while its valuation is still below $100 million.

Just click here for details inside my free report
08/08/2024
8:25 AM
Avadel Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/08/2024
6:12 AM
Avadel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:AVDL) was last updated on 8/7/2025 by MarketBeat.com Staff
From Our Partners